Levan, Macey L. http://orcid.org/0000-0002-4239-1252
Waldram, Madeleine M.
DiBrito, Sandra R.
Thomas, Alvin G.
Al Ammary, Fawaz
Ottman, Shane
Bannon, Jaclyn
Brennan, Daniel C.
Massie, Allan B.
Scalea, Joseph
Barth, Rolf N.
Segev, Dorry L.
Garonzik-Wang, Jacqueline M.
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (K01DK114388, F32DK105600, K23DK115908, K01DK101677)
National Institute of Diabetes and Digestive and Kidney Diseases (K24DK101828)
Living Legacy Foundation of Maryland (N/A)
National Heart, Lung, and Blood Institute (T32HL007055)
Article History
Received: 29 April 2019
Accepted: 21 October 2020
First Online: 9 November 2020
Ethics approval and consent to participate
: This study was approved by the Johns Hopkins School of Medicine IRB (IRB00126158) and the University of Maryland Medical Center IRB (HP-00081637). Patients must provide written or verbal informed consent before any study procedures occur. If study personnel are unable to contact the patient to obtain written informed consent through in-person recruitment, they will contact the patient to obtain verbal informed consent via telephone. To obtain verbal consent, study personnel will use an IRB-approved telephone screening script to describe the study and an IRB-approved oral consent script to obtain verbal consent, and will then document the date on which verbal informed consent was obtained. Both the Johns Hopkins School of Medicine and University of Maryland Medical Center IRBs approved the procedure for verbal consent.
: Not applicable.
: The authors declare that they have no competing interests.